These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 141095)

  • 21. Cause and course in a series of patients with sporadic chorea.
    Piccolo I; Defanti CA; Soliveri P; Volontè MA; Cislaghi G; Girotti F
    J Neurol; 2003 Apr; 250(4):429-35. PubMed ID: 12700907
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clonazepam in the treatment of choreiform activity.
    Peiris JB; Boralessa H; Lionel ND
    Med J Aust; 1976 Feb; 1(8):225-7. PubMed ID: 131236
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Proposal for the introduction of a new substance into hospital practice: dipropyl acetate sodium in the prevention and treatment of alcoholic delirium].
    Bonfiglio G; Falli S; Pacini A
    Minerva Med; 1977 Dec; 68(63):4233-45. PubMed ID: 340985
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomized trial of amantadine in Huntington disease.
    O'Suilleabhain P; Dewey RB
    Arch Neurol; 2003 Jul; 60(7):996-8. PubMed ID: 12873857
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A study of chorea after tetrabenazine withdrawal in patients with Huntington disease.
    Frank S; Ondo W; Fahn S; Hunter C; Oakes D; Plumb S; Marshall F; Shoulson I; Eberly S; Walker F; Factor S; Hunt V; Shinaman A; Jankovic J
    Clin Neuropharmacol; 2008; 31(3):127-33. PubMed ID: 18520979
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Experiences with sodium 2-propyl valerate (Depakine) in the treatment of epilepsy].
    Trompetter-van Woerden ML; van der Zwan A
    Ned Tijdschr Geneeskd; 1977 Apr; 121(14):578-90. PubMed ID: 323732
    [No Abstract]   [Full Text] [Related]  

  • 27. [Efficacy of lithium carbonate in the treatment of Huntington's chorea].
    Candalino G; Fragassi NA; Campanella G
    Acta Neurol (Napoli); 1977; 32(6):862-71. PubMed ID: 147006
    [No Abstract]   [Full Text] [Related]  

  • 28. Valproate sodium: a controlled clinical trial including monitoring of drug levels.
    Gram L; Wulff K; Rasmussen KE; Flachs H; Würtz-Jorgensen A; Sommerbeck KW; Lohren V
    Epilepsia; 1977 Jun; 18(2):141-8. PubMed ID: 326542
    [No Abstract]   [Full Text] [Related]  

  • 29. Fluphenazine decanoate in the treatment of chorea: a double-blind study.
    Terrence CF
    Curr Ther Res Clin Exp; 1976 Aug; 20(2):177-83. PubMed ID: 133787
    [No Abstract]   [Full Text] [Related]  

  • 30. [Trial of a new antiepileptic drug, magnesium dipropyl acetate].
    de Pasquet EG; Gomensoro JB; de Bustos LF; Tenzer SM
    Acta Neurol Latinoam; 1973; 19(1-4):119-28. PubMed ID: 4619958
    [No Abstract]   [Full Text] [Related]  

  • 31. [Treatment of pyknoleptic petit mal epilepsy and juvenile myoclonic epilepsy with dipropyl acetate (Deprakine). A pilot study of therapy-resistant patients during control of plasma concentration].
    Schroll M; Naestoft J; Lund M
    Ugeskr Laeger; 1977 May; 139(18):1073-7. PubMed ID: 404744
    [No Abstract]   [Full Text] [Related]  

  • 32. [Clinical study of the normothymic effect of dipropylacetamide].
    Semadeni GW
    Acta Psychiatr Belg; 1976 May; 76(3):458-66. PubMed ID: 798467
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A child with peculiar movements: Sydenham chorea].
    Munts AG; Wennekes MJ; Koehler PJ
    Ned Tijdschr Geneeskd; 2003 Feb; 147(6):257-60. PubMed ID: 12621982
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Combined suxilep-depakine (dipropylacetate) therapy in children with suxilep-resistant pyknolepsy].
    Todt H; Wünsche W; Korth G
    Kinderarztl Prax; 1977 Apr; 45(4):175-6. PubMed ID: 406476
    [No Abstract]   [Full Text] [Related]  

  • 35. Short-term effects of tetrabenazine on chorea associated with Huntington's disease.
    Kenney C; Hunter C; Davidson A; Jankovic J
    Mov Disord; 2007 Jan; 22(1):10-3. PubMed ID: 17078062
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Approach to a combined pharmacologic therapy of childhood hyperkinesis.
    Knobel M
    Behav Neuropsychiatry; 1974 Apr-1975 Mar; 6(1-12):87-90. PubMed ID: 4619768
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term treatment of juvenile Huntington's chorea with dipropylacetic acid.
    Bachman DS; Butler IJ; McKhann GM
    Neurology; 1977 Feb; 27(2):193-7. PubMed ID: 138101
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sydenham's chorea-clinical characteristics of nine patients.
    Davutoglu V; Kilinc M; Dinckal H; Soydinc S; Sezen Y
    Int J Cardiol; 2004 Sep; 96(3):483-4. PubMed ID: 15301906
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rational approaches to the pharmacotherapy of chorea.
    Chase TN
    Res Publ Assoc Res Nerv Ment Dis; 1976; 55():337-50. PubMed ID: 137504
    [No Abstract]   [Full Text] [Related]  

  • 40. [Influence of the Benzodiazepine-derivative Ro 06-9098/000 on choreo-athetotic syndromes (author's transl)].
    Girke W; Lieske V
    Pharmakopsychiatr Neuropsychopharmakol; 1977 Sep; 10(5):281-5. PubMed ID: 30103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.